financetom
Business
financetom
/
Business
/
US CFPB asks to exit Biden-era case against MoneyGram
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US CFPB asks to exit Biden-era case against MoneyGram
Apr 8, 2025 8:32 AM

(Reuters) - The top U.S. watchdog for consumer finance has asked a federal court to withdraw from the agency's own 2022 case against MoneyGram, leaving the New York attorney general as the sole plaintiff, according to court papers.

Under then-President Joe Biden, the agency had joined New York in accusing the cash transfer company of repeatedly and unfairly violating a federal rule designed to make it easier for people to send money to friends and family outside the United States.

In a motion filed on Monday, the Consumer Financial Protection Bureau, which has retreated from pending enforcement cases amid Trump administration efforts to dismantle the agency, said it could not seek a dismissal because New York officials were also suing.

Representatives for the CFPB, the New York attorney general's office and MoneyGram did not immediately respond to requests for comment.

The case had faced lengthy delays while legal challenges to the constitutionality of the CFPB's funding structure worked their way through the courts, arguments the U.S. Supreme Court ultimately rejected last year.

The CFPB has now dismissed at least nine of the two dozen enforcement cases that were pending when the Trump administration took control in February while federal judges have paused at least seven more. Cases concerning Experian and Comerica Bank continue.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved